Scientific program

THURSDAY, OCTOBER 1, 2020.
08:30-17:00 Registration of participants
1.CARDIOMYOPATHIES-AMYLOIDOSIS: IMPORTANCE OF NUCLEAR MEDICINE
Chairpersons: Arsen Ristić, Dragana Šobić Šaranović
09:00-09:15 Arsen Ristić, Belgrade Amyloidosis – cardiologist view
09:15-09:30 Sophia Koukouraki, Heraklion Planar and hybrid SPECT/CT cardiac imaging in the assessment of cardiac transthyretin amyloidosis – Crete experience
09:30-09:45 Ružica Maksimović, Belgrade MRI in cardiac amyloidosis
09:45-10:00 Venjamin Majstorov, Skopje Cardiac imaging in the assessment of cardiac transthyretin amyloidosis – North Macedonia experience
10:00-10:15 Dragana Sobic Saranovic, Belgrade Whole body DPD scintigraphy in cardiac transthyretin amyloidosis – experience of Center of Nuclear Medicine CCS
10:15-10:25 Discussion
2. ARTIFICIAL INTELLIGENCE IN CARDIOVASCULAR MEDICINE
Chairpersons: Marcus Hacker, Danijela Trifunović Zamaklar
10:30-10:45 Marcus Hacker, Vienna Artificial Intelligence in nuclear medicine
10:45-11:00 Marko Grahovac, Vienna AI algorithms in the multimodal imaging
11:00-11:15 Danijela Trifunovic Zamaklar, Belgrade Artificial intelligence in echocardiogaphy
11:15-11:25 Discussion
3. REVASCULARIZATION: IMPORTANCE OF ISCHEMIA AND VIABILITY ASSESSMENT
Chairpersons: Goran Stanković, Vojislav Giga
11:30-11:45 Goran Stanković, Belgrade Importance od functional tests: interventional cardiologist view
11:45-12:00 Pushan Baradwaj, Singapure SPECT in myocardial viability assessment
12:00-12:15 Vojislav Giga, Belgrade Noninvasive assessment of CAD: is there a method of chioice?
12:15-12:30 Radosav Vidaković, Belgrade Assessment of anatomy and function in coronary artery disease – role of CT and MRI
12:30-12:40 Discussion
OPENING CEREMONY
13:00-13:30 Dragana Šobić Šaranović,Belgrade Welcome, Cardiovascular nuclear medicine in the era of multimodality imaging
Vera Artiko, Belgrade The role of Center of Nuclear Medicine, CCS in cardiovascular nuclear medicine
Dean/Vise Dean Appointment of Visiting professor
13:30-13:45 Diana Paez, IAEA Reducing Disparities in Access to Healthcare
WELCOME RECEPTION
13:45-14:30
4. QUANTIFICATION OF CORONARY FLOW AND ISCHEMIA: IS IT IMPORTANT?
Chairpersons: Branko Beleslin, Sabina Dizdarević
14:30-14:45 Raffaele Giubbini, Brescia Measuring myocardial blood flow in the era of multimodality imaging
14:45-15:00 Branko Beleslin, Belgrade Complex relation between invasive flow evaluation and ischemia! How to define myocardial ischemia in 2020?
15:00-15:15 Ana Djordjević Dikić, Belgrade Diagnosis and risk stratification of coronary microvascular disease: Role of stress testing and noninvasive imaging
15:15-15:30 Sabina Dizdarević, Brighton Role of gated Myocardial perfusion in pre operative risk assessment prior to AAA repair
15:30-15:40 Discussion
5. CARDIOVASCULAR INFECTION AND INFLAMMATION
Chairpersons: Raluca Mititelu, Isidora Grozdić Milojević
15:45-16:00 Sobhan Vinjamuri, Liverpool Incidental cardiac uptake on Ga68 DOTA scans. What does it mean?
16:00-16:15 Jovica Šaponjski, Belgrade Role of MSCT in vasculitis
16:15-16:30 Isidora Grozdic Milojevic, Belgrade The role of FDG PET/CT in cardiac sarcoidosis
16:30-16:45 Raluca Mititelu, Bucharest The role of PET/CT in endocarditis
16:45-17:00 Vasilios Prasopoulos, Athens The role of FDG PET/CT in the investigation of clinical suspicious of vasculitis
17:00-17:10 Discussion
FRIDAY, OCTOBER 2, 2020
09:00-12:00 Registration of participants
6. CARDIO-ONCOLOGY AND CARDIO-NEUROLOGY: IMPORTANCE IN CLINICAL PRACTICE
Chairpersons: Branislava Ivanović, Snežana Šušnjar
09:00-09:15 Branislava Ivanović, Belgrade Cardio-oncology:The mirror has two faces
09:15-09:30 Snežana Šušnjar, Belgrade Why oncologists need cardiologists?
09:30-09:45 Jelena Petrović, Dragana Šobić Šaranović, Belgrade MUGA scan in cardiac toxicity
09:45-10:00 Maria Koutelu, Athens Cardiac neurotransmission imaging in heart diseases
10:00-10:15 Milica Stojijkovic,Leposava Brajković, Dragana Šobić Šaranović, Belgrade Cardiac neurotransmission imaging in neurological disorders: eight years of experience Center of Nuclear Medicine, CCS
10:15-10:25 Discussion
7. CHRONIC CORONARY SYNDROME AND NUCLEAR MEDICINE
Chairpersons: Nebojša Kozarević, Branislav Baškot
10:30-10:45 Siniša Stanković, Banja Luka SPECT MPI in Diabetes type 2 patients: expirience in Banja Luka
10:45-11:00 Jasna Mihailovic, Novi Sad Myocardial pefusion imaging in low risk patients for coronary artery disease with symptoms
11:00-11:15 Amela Begić, Sarajevo Myocardial perfusion imaging in detection of ischemia: expirience in Sarajevo
11:15-11:30 Branislav Baškot, Belgrade SPECT MPI in chronic coronary syndrome: expiriencein private practice
11:30-11:45 Nebojša Kozarević, Belgrade SPECT MPI in microvascular disease
11:45-12:00 Miloš Stević, Niš Myocardial perfusion imaging in detection of ischemia: expirience in Niš
12:00-12:15 Katarina Nikoletic, Drummen Nuclear cardiology in Norway
12:15-12:25 Discussion
12:30-13:00 Coffee break
8. POSTER WALK
Chairpersons: Miloš Stević, Strahinja Odalović
13:00-14:00
9.POSTER PRESENTATIONS OF TECHNOLOGISTS IN NUCLEAR MEDICINE
Chairpersons: Tatjana Krkalović, Zorica Obradović
14:00-15:00
THURSDAY, SEPTEMBER 1, 2020
08:30-17:00 Registration of participants
1.CARDIOMYOPATHIES-AMYLOIDOSIS: IMPORTANCE OF NUCLEAR MEDICINE
Chairpersons:
09:00-09:15 Arsen Ristić, Belgrade TBD (Amyloidosis – cardiologist view)
09:15-09:30 Sophia Koukouraki, Heraklion Planar and hybrid SPECT/CT cardiac imaging in the assessment of cardiac transthyretin amyloidosis – Crete experience
09:30-09:45 Ružica Maksimović, Belgrade TBD
09:45-10:00 Venjamin Majstorov, Skopje Cardiac imaging in the assessment of cardiac transthyretin amyloidosis – North Macedonia experience
10:00-10:15 Dragana Sobic Saranovic, Belgrade Whole body DPD scintigraphy in cardiac transthyretin amyloidosis – experience of Center of Nuclear Medicine CCS
10:15-10:25 Discussion
2. ARTIFICIAL INTELLIGENCE IN CARDIOVASCULAR MEDICINE
Chairpersons:
10:30-10:45 Marcus Hacker, Vienna Artificial Intelligence in nuclear medicine
10:45-11:00 Marko Grahovac, Vienna AI algorithms in the multimodal imaging
11:00-11:15 Danijela Trifunovic Zamaklar, Belgrade Artificial intelligence in echocardiogaphy
11:15-11:25 Discussion
3. REVASCULARIZATION: IMPORTANCE OF ISCHEMIA AND VIABILITY ASSESSMENT
Chairpersons:
11:30-11:45 Goran Stanković, Belgrade TBD (Importance od functional tests: interventional cardiologist view )
11:45-12:00 Pushan Baradwaj, Singapure TBD (SPECT)
12:00-12:15 Vojislav Giga, Belgrade TBD Noninvasive assessment of CAD: is there a method of chioice?
12:15-12:30 Radosav Vidaković, Belgrade TBD (MSCT/MRI
12:30-12:40 Discussion
OPENING CEREMONY
13:00-13:30 Dragana Šobić Šaranović,Belgrade Welcome, Cardiovascular nuclear medicine in the era of multimodality imaging
Vera Artiko, Belgrade The role of Center of Nuclear Medicine, CCS in cardiovascular nuclear medicine
Dean/Vise Dean Appointment of Visiting professor
13:30-13:45 Diana Paez, IAEA Reducing Disparities in Access to Healthcare
WELCOME RECEPTION
13:45-14:30
4. QUANTIFICATION OF CORONARY FLOW AND ISCHEMIA: IS IT IMPORTANT?
Chairpersons:
14:30-14:45 Raffaele Giubbini, Brescia Measuring myocardial blood flow in the era of multimodality imaging
14:45-15:00 Branko Beleslin, Belgrade Complex relation between invasive flow evaluation and ischemia! How to define myocardial ischemia in 2020?
15:00-15:15 Ana Djordjević Dikić, Belgrade Diagnosis and risk stratification of coronary microvascular disease: Role of stress testing and noninvasive imaging
15:15-15:30 Sabina Dizdarević, Brighton Role of gated Myocardial perfusion in pre operative risk assessment prior to AAA repair
15:30-15:40 Discussion
5. CARDIOVASCULAR INFECTION AND INFLAMMATION
Chairpersons:
15:45-16:00 Sobhan Vinjamuri, Liverpool Incidental cardiac uptake on Ga68 DOTA scans. What does it mean?
16:00-16:15 TBD
16:15-16:30 Isidora Grozdic Milojevic, Belgrade TBD (The role of FDG PET/CT in cardiac sarcoidosis)
16:30-16:45 Raluca Mititelu, Bucharest TBD (The role of PET/CT in endocarditis)
16:45-17:00 Vasilios Prasopoulos, Athens TBD
17:00-17:10 Discussion
COCKTAIL – AEROKLUB
19:30-22:30
FRIDAY, OCTOBER 2, 2020
09:00-12:00 Registration of participants
6. POSTER WALK
Chairpersons:
09:30-10:15
7. CHRONIC CORONARY SYNDROME AND NUCLEAR MEDICINE
Chairpersons:
10:15-10:30 Siniša Stanković, Banja Luka SPECT MPI in Diabetes type 2 patients
10:30-10:45 Branislav Baškot, Belgrade SPECT MPI in chronic coronary syndrome
10:45-11:00 Jovica Šaponjski, Belgrade CT in nuclear cardiology, MSCT in chronic coronary syndrome
11:00-11:15 Nebojša Kozarević, Belgrade SPECT MPI in microvascular disease
11:15-11:30 Miloš Stević, Niš TBD
11:30-11:40 Discussion
8. CARDIO-ONCOLOGY AND CARDIO-NEUROLOGY: IMPORTANCE IN CLINICAL PRACTICE
Chairpersons:
11:45-12:00 Branislava Ivanović, Belgrade TBD (Multimodality imaging in cardio-oncology)
12:00-12:15 Snežana Šušnjar, Belgrade Why oncologists need cardiologists?
12:15-12:30 Jelena Šaponjski, Dragana Šobić Šaranović, Belgrade MUGA scan in cardiac toxicity
12:30-12:45 Maria Koutelu, Athens TBD (Cardiac neurotransmission imaging in heart diseases)
12:45-13:00 Milica Stojijkovic, Dragana Šobić Šaranović, Belgrade Cardiac neurotransmission imaging in neurological disorders: eight years of experience Center of Nuclear Medicine, CCS
13:00-13:10 Discussion
13:15-14:00 COCKTAIL
9.POSTER PRESENTATIONS OF TECHNOLOGISTS IN NUCLEAR MEDICINE
14:00-15:00 Chairpersons: